Verano Holdings (VRNO) EBT Margin Growth (1y) (2022 - 2026)

Verano Holdings (VRNO) EBT Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 342.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -166.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,404.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,258.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 8,812.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2,773.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 132.00
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn -576.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -576.00
Dec 31, 2025 6,227.00
Sep 30, 2025 -893.00
Jun 30, 2025 397.00
Mar 31, 2025 -77,649.00
Dec 31, 2024 -13,196.00
Sep 30, 2024 -992.00
Jun 30, 2024 -230.00
Mar 31, 2024 77,087.00
Dec 31, 2023 8,200.00
Sep 30, 2023 -34.00
Jun 30, 2023 568.00
Mar 31, 2023 -425.00
Dec 31, 2022 -11,018.00
Sep 30, 2022 427.00
Jun 30, 2022 365.00